A recent study demonstrated that rare APOB variants predicted to alter protein function were enriched in Italian patients with NAFLD-HCC and associated with higher HDL cholesterol lower triglycerides [76]. Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.